Global Next-Generation Sequencing (NGS) Services Supply, Demand and Key Producers, 2026-2032
Description
The global Next-Generation Sequencing (NGS) Services market size is expected to reach $ 75300 million by 2032, rising at a market growth of 16.0% CAGR during the forecast period (2026-2032).
Next-Generation Sequencing (NGS) Services refer to comprehensive genetic analysis solutions based on high-throughput sequencing platforms, enabling the detection and analysis of genomic, transcriptomic, and epigenomic information at multiple levels. By leveraging parallelized, large-scale, and high-precision sequencing, NGS dramatically improves the efficiency and accuracy of genetic data acquisition, generating massive DNA or RNA sequence datasets in a single run. These services encompass the entire workflow, including sample preparation, library construction, sequencing operations, data processing, and bioinformatics analysis, while offering customized solutions for diverse needs such as research, clinical diagnostics, drug development, agricultural breeding, and microbiology studies. With advantages in cost efficiency, data depth, and application breadth, NGS services have become an essential infrastructure and innovation driver in precision medicine, life sciences, and the biotechnology industry.
The accelerated implementation of global precision medicine strategies and continuous advancements in bioinformatics are creating vast growth opportunities for the NGS services market. Increased government funding for genomics research and clinical translation projects such as early cancer screening is driving demand expansion among hospitals, research institutions, and biopharmaceutical companies. With significant reductions in sequencing costs and faster turnaround times, NGS has transitioned from exploratory research to large-scale clinical applications, covering areas such as tumor profiling, companion diagnostics, pathogen detection, and rare disease screening. Across the value chain, deeper collaborations between platform technology providers, service operators, and downstream application sectors are accelerating the adoption of new service models and value-added applications.
Despite rapid growth, the NGS services market faces challenges such as the lack of standardized data interpretation protocols, stringent regulatory requirements for clinical applications, and compliance risks related to data security. Regulatory differences across countries and regions increase the complexity of cross-border operations. High-quality bioinformatics analysis depends on experienced technical teams and robust computing infrastructure, creating barriers to entry. Certain niche segments demand extremely high sequencing accuracy and sensitivity, requiring continuous investment in R&D and quality control. Additionally, as market competition intensifies, balancing price pressures with differentiated service capabilities has become a critical test for business sustainability and expansion.
In the coming years, downstream demand for NGS services will diversify and integrate across multiple sectors. In healthcare, personalized treatment and early disease screening will continue to expand, particularly in the precision diagnosis of cancer, infectious diseases, and genetic disorders. In the biopharmaceutical industry, NGS will play a key role in new drug target discovery, elucidating drug response mechanisms, and stratifying patients in clinical trials. Agriculture and environmental sciences will further leverage NGS for crop improvement, animal breeding, and microbiome monitoring. Meanwhile, AI-driven automated analysis and cloud-based data collaboration will drive NGS services toward higher efficiency and broader accessibility, meeting the growing need for real-time, large-scale, multidimensional genetic information in both research and industrial applications.
This report studies the global Next-Generation Sequencing (NGS) Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Next-Generation Sequencing (NGS) Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Next-Generation Sequencing (NGS) Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Next-Generation Sequencing (NGS) Services total market, 2021-2032, (USD Million)
Global Next-Generation Sequencing (NGS) Services total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Next-Generation Sequencing (NGS) Services total market, key domestic companies, and share, (USD Million)
Global Next-Generation Sequencing (NGS) Services revenue by player, revenue and market share 2021-2026, (USD Million)
Global Next-Generation Sequencing (NGS) Services total market by Type, CAGR, 2021-2032, (USD Million)
Global Next-Generation Sequencing (NGS) Services total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Next-Generation Sequencing (NGS) Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Thermo Fisher Scientific, Macrogen, Oxford Nanopore, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Next-Generation Sequencing (NGS) Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Next-Generation Sequencing (NGS) Services Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Next-Generation Sequencing (NGS) Services Market, Segmentation by Type:
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
Global Next-Generation Sequencing (NGS) Services Market, Segmentation by Application:
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
Companies Profiled:
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Thermo Fisher Scientific
Macrogen
Oxford Nanopore
Novogene
Pacific Biosciences
Azenta Life Sciences
Key Questions Answered
1. How big is the global Next-Generation Sequencing (NGS) Services market?
2. What is the demand of the global Next-Generation Sequencing (NGS) Services market?
3. What is the year over year growth of the global Next-Generation Sequencing (NGS) Services market?
4. What is the total value of the global Next-Generation Sequencing (NGS) Services market?
5. Who are the Major Players in the global Next-Generation Sequencing (NGS) Services market?
6. What are the growth factors driving the market demand?
Next-Generation Sequencing (NGS) Services refer to comprehensive genetic analysis solutions based on high-throughput sequencing platforms, enabling the detection and analysis of genomic, transcriptomic, and epigenomic information at multiple levels. By leveraging parallelized, large-scale, and high-precision sequencing, NGS dramatically improves the efficiency and accuracy of genetic data acquisition, generating massive DNA or RNA sequence datasets in a single run. These services encompass the entire workflow, including sample preparation, library construction, sequencing operations, data processing, and bioinformatics analysis, while offering customized solutions for diverse needs such as research, clinical diagnostics, drug development, agricultural breeding, and microbiology studies. With advantages in cost efficiency, data depth, and application breadth, NGS services have become an essential infrastructure and innovation driver in precision medicine, life sciences, and the biotechnology industry.
The accelerated implementation of global precision medicine strategies and continuous advancements in bioinformatics are creating vast growth opportunities for the NGS services market. Increased government funding for genomics research and clinical translation projects such as early cancer screening is driving demand expansion among hospitals, research institutions, and biopharmaceutical companies. With significant reductions in sequencing costs and faster turnaround times, NGS has transitioned from exploratory research to large-scale clinical applications, covering areas such as tumor profiling, companion diagnostics, pathogen detection, and rare disease screening. Across the value chain, deeper collaborations between platform technology providers, service operators, and downstream application sectors are accelerating the adoption of new service models and value-added applications.
Despite rapid growth, the NGS services market faces challenges such as the lack of standardized data interpretation protocols, stringent regulatory requirements for clinical applications, and compliance risks related to data security. Regulatory differences across countries and regions increase the complexity of cross-border operations. High-quality bioinformatics analysis depends on experienced technical teams and robust computing infrastructure, creating barriers to entry. Certain niche segments demand extremely high sequencing accuracy and sensitivity, requiring continuous investment in R&D and quality control. Additionally, as market competition intensifies, balancing price pressures with differentiated service capabilities has become a critical test for business sustainability and expansion.
In the coming years, downstream demand for NGS services will diversify and integrate across multiple sectors. In healthcare, personalized treatment and early disease screening will continue to expand, particularly in the precision diagnosis of cancer, infectious diseases, and genetic disorders. In the biopharmaceutical industry, NGS will play a key role in new drug target discovery, elucidating drug response mechanisms, and stratifying patients in clinical trials. Agriculture and environmental sciences will further leverage NGS for crop improvement, animal breeding, and microbiome monitoring. Meanwhile, AI-driven automated analysis and cloud-based data collaboration will drive NGS services toward higher efficiency and broader accessibility, meeting the growing need for real-time, large-scale, multidimensional genetic information in both research and industrial applications.
This report studies the global Next-Generation Sequencing (NGS) Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Next-Generation Sequencing (NGS) Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Next-Generation Sequencing (NGS) Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Next-Generation Sequencing (NGS) Services total market, 2021-2032, (USD Million)
Global Next-Generation Sequencing (NGS) Services total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Next-Generation Sequencing (NGS) Services total market, key domestic companies, and share, (USD Million)
Global Next-Generation Sequencing (NGS) Services revenue by player, revenue and market share 2021-2026, (USD Million)
Global Next-Generation Sequencing (NGS) Services total market by Type, CAGR, 2021-2032, (USD Million)
Global Next-Generation Sequencing (NGS) Services total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Next-Generation Sequencing (NGS) Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Thermo Fisher Scientific, Macrogen, Oxford Nanopore, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Next-Generation Sequencing (NGS) Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Next-Generation Sequencing (NGS) Services Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Next-Generation Sequencing (NGS) Services Market, Segmentation by Type:
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
Global Next-Generation Sequencing (NGS) Services Market, Segmentation by Application:
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
Companies Profiled:
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Thermo Fisher Scientific
Macrogen
Oxford Nanopore
Novogene
Pacific Biosciences
Azenta Life Sciences
Key Questions Answered
1. How big is the global Next-Generation Sequencing (NGS) Services market?
2. What is the demand of the global Next-Generation Sequencing (NGS) Services market?
3. What is the year over year growth of the global Next-Generation Sequencing (NGS) Services market?
4. What is the total value of the global Next-Generation Sequencing (NGS) Services market?
5. Who are the Major Players in the global Next-Generation Sequencing (NGS) Services market?
6. What are the growth factors driving the market demand?
Table of Contents
128 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Next-Generation Sequencing (NGS) Services Companies Competitive Analysis
- 4 United States VS China VS Rest of World (by Headquarter Location)
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
